{"product_id":"global-diagnostics-pcr-market-growth-2023-2029","title":"Global Diagnostics PCR Market Growth 2023-2029","description":"\u003cp\u003eGlobal Diagnostics PCR Market Growth 2023-2029\u003c\/p\u003e\n\n\u003cp\u003ePCR is the Gold Standard in Diagnostic Testing. Polymerase chain reaction (PCR) is able to copy and multiply specific target DNA molecules has opened the door to diagnosing diseases across multiple areas quickly, accurately, and as time progresses at lower cost. Polymerase chain reaction (PCR) is a quick, easy way to create unlimited copies of DNA from just one original strand. These millions of copies of a section of DNA are made in just a few hours with the goal to recreate enough DNA for multiple testing uses, such as sequencing or infection identification.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Diagnostics PCR Industry Forecast” looks at past sales and reviews total world Diagnostics PCR sales in 2022, providing a comprehensive analysis by region and market sector of projected Diagnostics PCR sales for 2023 through 2029. With Diagnostics PCR sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostics PCR industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global Diagnostics PCR landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostics PCR portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Diagnostics PCR market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostics PCR and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostics PCR.\u003cbr\u003e\nThe global Diagnostics PCR market size is projected to grow from US$ 525.3 million in 2022 to US$ 615.2 million in 2029; it is expected to grow at a CAGR of 615.2 from 2023 to 2029.\u003cbr\u003e\nGlobal Diagnostics PCR key players include Thermo Fisher Scientific, Bio-rad, Roche, Qiagen, Bioer, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 40%, followed by Europe and China, total have a share over 40 percent. In terms of product, Real-Time PCR is the largest segment, with a share about 55%. And in terms of application, the largest application is Hospital, followed by Independent Laboratories.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of Diagnostics PCR market by product type, application, key manufacturers and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n Real-Time PCR\u003cbr\u003e\n Digital PCR\u003cbr\u003e\n Other\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Hospital\u003cbr\u003e\n Independent Laboratories\u003cbr\u003e\n Other\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Thermo Fisher Scientific\u003cbr\u003e\n Roche\u003cbr\u003e\n Bio-rad\u003cbr\u003e\n Qiagen\u003cbr\u003e\n Agilent\u003cbr\u003e\n Bioer\u003cbr\u003e\n Analytik Jena\u003cbr\u003e\n Techne\u003cbr\u003e\n Biosynex\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Addressed in this Report\u003cbr\u003e\nWhat is the 10-year outlook for the global Diagnostics PCR market?\u003cbr\u003e\nWhat factors are driving Diagnostics PCR market growth, globally and by region?\u003cbr\u003e\nWhich technologies are poised for the fastest growth by market and region?\u003cbr\u003e\nHow do Diagnostics PCR market opportunities vary by end market size?\u003cbr\u003e\nHow does Diagnostics PCR break out type, application?\u003cbr\u003e\nWhat are the influences of COVID-19 and Russia-Ukraine war?\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 99 Pages \/ MCW16226182","offer_id":47640122097970,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-diagnostics-pcr-market-growth-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}